{"id":28312,"date":"2017-03-16T15:41:35","date_gmt":"2017-03-16T14:41:35","guid":{"rendered":"http:\/\/ibecbarcelona.eu\/ca\/per-a-investigadors\/joint-units-2\/"},"modified":"2022-07-15T10:00:46","modified_gmt":"2022-07-15T08:00:46","slug":"joint-units","status":"publish","type":"page","link":"https:\/\/ibecbarcelona.eu\/ca\/research\/joint-units\/","title":{"rendered":"Joint Units"},"content":{"rendered":"\n

IBEC\u2019s Joint Research Units with industry provide an operational framework for close interaction on various R&D activities related to healthcare. <\/strong><\/h4>\n\n\n\n

Researchers and industry technicians share a host of know-how and in-house capabilities to develop and bring to market point-of-care diagnostic products and other medical devices and technologies.<\/p>\n\n\n

\n

GENOMICA<\/h2>\n
\n\n\n\n\n

IBEC and Genomica\u00a0 joint unit for research and development of diagnostic devices<\/h4>\n\n\n\n
\"genomica\"<\/figure><\/div>\n\n\n\n

The Institute for Bioengineering for Catalonia (IBEC) and Genomica S.A.U. (Grupo Zeltia), the leading Spanish company in molecular diagnostics, created a Joint Research Unit that will provide an operational framework for close interaction on various R&D activities related to healthcare.<\/strong><\/p>\n\n\n\n

The unit, which is located at IBEC\u2019s headquarters in Barcelona, will see researchers and industry technicians sharing a host of know-how and in-house capabilities to develop and bring to market point-of-care diagnostic products and other medical devices and technologies.<\/p>\n\n\n\n

IBEC\u2019s researchers in the unit will supply the scientific knowledge with their expertise in biosensors, micro- and nanofabrication, signal processing and bioengineering, while the members from Genomica\u2019s side will offer market intelligence, clinical evaluation and regulations, and diagnostics know-how.<\/p>\n\n\n\n

It\u2019s the first time that IBEC\u2019s researchers will physically work together alongside industry personnel, though the institute already has several existing collaborations and research agreements \u2013 with companies such as Ferrer International, Ficosa and Grifols, as well as Genomica itself \u2013 related to the development of specific projects and the transfer of technologies.<\/p>\n\n\n\n

\u201cThe establishment of our joint unit bridges the often wide gap between research and industry, and will enable many of our health-based research areas that we have at IBEC to reach the market and the patient sooner,\u201d said Dr. Josep Samitier, Director of IBEC. \u201cThis long-term collaboration with Genomica demonstrates the confidence that this major company \u2013 currently the leader in forensic identification in Spain and an international benchmark \u2013 has in IBEC as the right partner to offer the deep scientific knowledge and state-of-the-art scientific instrumentation to respond to specific industrial needs in the area of healthcare technology.<\/p>\n\n\n\n<\/div>

ISGlobal<\/h2>\n
\n\n\n\n\n

Nanomalaria group joint unit<\/h4>\n\n\n\n

The Nanomalaria group is a joint unit affiliated with IBEC and the Barcelona Institute for Global Health (ISGlobal), located in the Esther Koplowitz Centre near Hospital Cl\u00ednic (Barcelona).<\/strong><\/p>\n\n\n\n

The current activity of the group is focused on the development of nanomedicine-based systems to be applied to malaria prophylaxis, diagnosis and therapy.<\/p>\n\n\n\n

For more information, visit the group’s page<\/a>.<\/p>\n\n\n\n<\/div>

IGTP<\/h2>\n
\n\n\n\n\n

Working together against respiratory diseases<\/h4>\n\n\n\n

A joint research Unit between IBEC and Hospital Universitari Germans Trias i Pujol is coordinated by Raimon Jan\u00e9, head of IBEC’s Biomedical Signal Processing and Interpretation group, and the hospital’s Miquel \u00c0ngel Gasull. <\/strong><\/p>\n\n\n\n

\u201cAmong the objectives of this joint unit will be the consolidation of current research projects and the proposal of new, innovative interdisciplinary projects,\u201d says Raimon. \u201cIt will also enable us to share scientific staff, equipment and clinical laboratories.\u201d<\/p>\n\n\n\n

In 2013, the Joint Research Unit developed a collaborative project in respiratory sound analysis. The clinicians performed experiments with patients with asthma and other respiratory diseases, while advanced signal interpretation techniques developed by IBEC\u2019s group improved the capability of early diagnosis in these kinds of diseases.<\/p>\n\n\n\n

They also developed a new method to evaluate the signals produced by the respiratory muscles to detect and quantify the level of muscular weakness caused by pathologies such as COPD. The study was conducted in the hospital\u2019s Respiratory Function Laboratory.<\/p>\n\n\n\n<\/div>

VHIR<\/h2>\n
\n\n\n\n\n

Bacterial Infections form alliance with Infectious Diseases<\/h4>\n\n\n\n
\n